First-Line Treatment for Alcohol Withdrawal Syndrome
Benzodiazepines are the gold standard first-line treatment for managing alcohol withdrawal syndrome due to their efficacy in reducing withdrawal symptoms and preventing seizures and delirium tremens. 1, 2
Benzodiazepine Selection
- Long-acting benzodiazepines (diazepam and chlordiazepoxide) are preferred for most patients as they provide better protection against seizures and delirium tremens due to their longer duration of action 1, 2
- Diazepam is typically administered at 5-10 mg every 6-8 hours orally, intravenously, or intramuscularly 1, 3
- For acute alcohol withdrawal, diazepam is indicated for symptomatic relief of acute agitation, tremor, impending or acute delirium tremens, and hallucinosis 3
- Chlordiazepoxide is an alternative option at doses of 25-100 mg every 4-6 hours orally 1, 2
- For patients with severe alcohol withdrawal, the FDA recommends diazepam at 10 mg, 3-4 times during the first 24 hours, reducing to 5 mg, 3-4 times daily as needed 3
Special Population Considerations
- Short and intermediate-acting benzodiazepines (lorazepam, oxazepam) are safer in patients with:
- Lorazepam is typically administered at 1-4 mg every 4-8 hours (6-12 mg/day) and doesn't rely on hepatic oxidation, making it safer for patients with liver impairment 1, 2
Adjunctive Treatments
- Thiamine (100-300 mg/day) must be administered to all patients with alcohol withdrawal to prevent Wernicke encephalopathy 1, 2
- Thiamine should always be given before any glucose-containing IV fluids to prevent precipitating acute thiamine deficiency 2
- Carbamazepine (200 mg every 6-8 hours) can be used as an alternative for seizure prevention 2
- Haloperidol (0.5-5 mg every 8-12 hours) may be used carefully for agitation or psychotic symptoms not controlled by benzodiazepines 2
Treatment Setting Determination
- Inpatient treatment is recommended for patients with:
- Outpatient management is appropriate for patients with mild to moderate withdrawal symptoms without additional risk factors for developing severe or complicated withdrawal 4
Monitoring and Treatment Duration
- The Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised (CIWA-Ar) can guide treatment intensity—scores >8 indicate moderate AWS and scores ≥15 indicate severe AWS requiring more aggressive treatment 2, 4
- Treatment with benzodiazepines should be tapered following resolution of withdrawal symptoms 2
- Treatment duration should not exceed 10-14 days to avoid the risk of benzodiazepine dependence 2
- Physicians should monitor outpatients with alcohol withdrawal syndrome daily for up to five days after their last drink 4
Common Pitfalls and Caveats
- Disulfiram should be avoided in patients with severe alcoholic liver disease due to potential hepatotoxicity 5, 1
- Naltrexone is not recommended in patients with alcoholic liver disease due to potential hepatotoxicity 5, 1
- The CIWA protocol should not be used alone for diagnosis of AWS as high scores may be seen in other conditions 2
- Neuroleptics alone can increase the risk of seizures when used as primary treatment for alcohol withdrawal 6
- Excessive water-sodium intake carries a risk of pulmonary edema in patients with heart disease 6